Overview
Operating performance impacted by COVID-19 disruption and departure of specialists in Victoria
Revenue
$145.4m
FY19 $152.0m ( 4.3%)
Adjusted EBIT
1,3,5
$24.4m
FY19 $32.7m ( 25.3%)
Adjusted EBITDA
1,2,3,4,5
$34.8m
FY19 $37.8m ( 8.0%)
Adjusted NPAT
1,3,4,5
$14.4m
FY19 $20.9m ( 31.2%)
Reported EBITDA
2,3
$32.8m
FY19 $37.2m ( 11.8%)
Reported NPAT
1,3,4
$11.7m
FY19 $19.9m ( 40.9%)
Note: Financial metrics include impact from COVID-19 and AASB16 Leases.
- Reported EBITDA adjusted by $2.0m, Reported EBIT adjusted by $2.6m and Reported NPAT by $2.7m. Refer to page 10 for reconciliation.
- EBITDA is a non-IFRS measure. EBITDA is defined as Earnings before interest, tax, depreciation and amortisation.
- FY20 includes impact from changes to AASB16 Lease accounting standard (EBITDA +7.2m, EBIT +$1.6m and NPAT +$0.3m).
- Attributable to ordinary members.
- Adjusted EBITDA, Adjusted EBIT and Adjusted NPAT are non-IFRS measures.
| $m | FY20 | FY19 | % change |
|---|---|---|---|
| Group Revenue | $145.4 | $152.0 | (4.3%) |
| EBITDA (1) | $32.8 | $37.2 | (11.8%) |
| Adjusted EBITDA (1)(2)(6) | $34.8 | $37.8 | (8.0%) |
| EBIT | $21.8 | $31.3 | (30.2%) |
| Adjusted EBIT (1)(6) | $24.4 | $32.7 | (25.3%) |
| NPAT attributable to ordinary shareholders | $11.7 | $19.9 | (40.9%) |
| Adjusted NPAT (1)(6) | $14.4 | $20.9 | (31.2%) |
| EPS (cents) | 4.6 | 8.4 | (45.2%) |
| DPS (cents) | 2.1 | 6.0 | (65.0%) |
| 30 June 20 | 30 June 19 | ||
| Net Debt (m) (3) | $4.2 | $84.7 | |
| Net Debt to Equity ratio (4) | 1.7% | 48.8% | |
| Return on Equity (pa.) (5) | 5.7% | 12.1% |
(1) Adjusted reflects non-regular items relating to transaction costs on acquisition activity, restructuring costs, certain pre-IPO patient claim, closure of interest rate swaps and work-in-progress Sydney CBD clinic premise operating costs. Refer to page 29.
(2) EBITDA is earnings before interest, tax, depreciation and amortisation. EBITDA is a non-IFRS measure which is used by the Group as a key indicator of underlying performance. This non-IFRS measure is not subject to audit or review.
(3) Debt less cash balances.
(4) Net debt to equity is debt divided by equity.
(5) Return on equity is Adjusted NPAT divided by closing equity.
(6) Adjusted EBITDA, Adjusted EBIT and Adjusted NPAT are non-IFRS measures.
